These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 36233312)
1. IDO1 Modulates the Sensitivity of Epithelial Ovarian Cancer Cells to Cisplatin through ROS/p53-Dependent Apoptosis. Wang H; Luo Y; Ran R; Li X; Ling H; Wen F; Yu T Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233312 [TBL] [Abstract][Full Text] [Related]
2. ABT737 reverses cisplatin resistance by targeting glucose metabolism of human ovarian cancer cells. Xu Y; Gao W; Zhang Y; Wu S; Liu Y; Deng X; Xie L; Yang J; Yu H; Su J; Sun L Int J Oncol; 2018 Sep; 53(3):1055-1068. PubMed ID: 30015875 [TBL] [Abstract][Full Text] [Related]
3. [Effect of circBIRC6 targeting miR-367-3p on cisplatin resistance of ovarian cancer cells]. Zhang J; Bai HJ Zhonghua Zhong Liu Za Zhi; 2021 Oct; 43(10):1062-1068. PubMed ID: 34695896 [No Abstract] [Full Text] [Related]
4. Tasquinimod enhances the sensitivity of ovarian cancer cells to cisplatin by regulating the Nur77-Bcl-2 apoptotic pathway. Lin Y; Liu YQ; Zhu KA; Hu MQ; Li Z; Min XJ Adv Clin Exp Med; 2024 Feb; 33(2):151-161. PubMed ID: 37501511 [TBL] [Abstract][Full Text] [Related]
5. [Establishment and biological characteristics of a platinum-resistance nude mouse model in epithelial ovarian cancer]. Shi L; Yu H; Zhang W; Li L; Wang Q Zhonghua Fu Chan Ke Za Zhi; 2014 Jul; 49(7):523-30. PubMed ID: 25327735 [TBL] [Abstract][Full Text] [Related]
6. HSPA8-mediated stability of the CLPP protein regulates mitochondrial autophagy in cisplatin-resistant ovarian cancer cells. Kou X; Yang X; Zhao Z; Li L Acta Biochim Biophys Sin (Shanghai); 2024 Mar; 56(3):356-365. PubMed ID: 38419499 [TBL] [Abstract][Full Text] [Related]
7. [Effect of MTRR gene on apoptosis and autophagy pathways in multiresistant epithelial ovarian cancer]. Chen J; Wang Q; Zhang W; Li L Zhonghua Fu Chan Ke Za Zhi; 2016 Apr; 51(4):285-92. PubMed ID: 27116987 [TBL] [Abstract][Full Text] [Related]
8. Interfering with the expression of EEF1D gene enhances the sensitivity of ovarian cancer cells to cisplatin. Xu Q; Liu Y; Wang S; Wang J; Liu L; Xu Y; Qin Y BMC Cancer; 2022 Jun; 22(1):628. PubMed ID: 35672728 [TBL] [Abstract][Full Text] [Related]
9. A Co-Delivery System of Curcumin and p53 for Enhancing the Sensitivity of Drug-Resistant Ovarian Cancer Cells to Cisplatin. Guo X; Fang Z; Zhang M; Yang D; Wang S; Liu K Molecules; 2020 Jun; 25(11):. PubMed ID: 32512936 [TBL] [Abstract][Full Text] [Related]
10. Expression of human dCTP pyrophosphatase 1 (DCTPP1) and its association with cisplatin resistance characteristics in ovarian cancer. Wang Y; Chen X; Chen Q; Liu T; Wu Y; Huang L; Chen Y J Cell Mol Med; 2024 May; 28(9):e18371. PubMed ID: 38686496 [TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA Linc00312 modulates the sensitivity of ovarian cancer to cisplatin via the Bcl-2/Caspase-3 signaling pathway. Zhang C; Wang M; Shi C; Shi F; Pei C Biosci Trends; 2018 Jul; 12(3):309-316. PubMed ID: 29952351 [TBL] [Abstract][Full Text] [Related]
12. Noscapine Increases the Sensitivity of Drug-Resistant Ovarian Cancer Cell Line SKOV3/DDP to Cisplatin by Regulating Cell Cycle and Activating Apoptotic Pathways. Shen W; Liang B; Yin J; Li X; Cheng J Cell Biochem Biophys; 2015 May; 72(1):203-13. PubMed ID: 25510462 [TBL] [Abstract][Full Text] [Related]
13. Lentivirus-Mediated RNAi silencing targeting ERCC1 reverses cisplatin resistance in cisplatin-resistant ovarian carcinoma cell line. Du P; Zhang X; Liu H; Chen L DNA Cell Biol; 2015 Jul; 34(7):497-502. PubMed ID: 25941922 [TBL] [Abstract][Full Text] [Related]
14. Murine double minute 2 siRNA and wild-type p53 gene therapy enhances sensitivity of the SKOV3/DDP ovarian cancer cell line to cisplatin chemotherapy in vitro and in vivo. Gu J; Tang Y; Liu Y; Guo H; Wang Y; Cai L; Li Y; Wang B Cancer Lett; 2014 Feb; 343(2):200-9. PubMed ID: 24161623 [TBL] [Abstract][Full Text] [Related]
15. Soluble CD40 ligands sensitize the epithelial ovarian cancer cells to cisplatin treatment. Qin L; Qiu H; Zhang M; Zhang F; Yang H; Yang L; Jia L; Qin K; Jia L; Dou X; Cheng L; Sang M; Zhang C; Shan B; Zhang Z Biomed Pharmacother; 2016 Apr; 79():166-75. PubMed ID: 27044825 [TBL] [Abstract][Full Text] [Related]
16. Roflumilast enhances cisplatin-sensitivity and reverses cisplatin-resistance of ovarian cancer cells via cAMP/PKA/CREB-FtMt signalling axis. Gong S; Chen Y; Meng F; Zhang Y; Li C; Zhang G; Huan W; Wu F Cell Prolif; 2018 Oct; 51(5):e12474. PubMed ID: 30069985 [TBL] [Abstract][Full Text] [Related]
17. Exosomal miR-21-5p derived from cisplatin-resistant SKOV3 ovarian cancer cells promotes glycolysis and inhibits chemosensitivity of its progenitor SKOV3 cells by targeting PDHA1. Zhuang L; Zhang B; Liu X; Lin L; Wang L; Hong Z; Chen J Cell Biol Int; 2021 Oct; 45(10):2140-2149. PubMed ID: 34288231 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA 1301 inhibits cisplatin resistance in human ovarian cancer cells by regulating EMT and autophagy. Yu JL; Gao X Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1688-1696. PubMed ID: 32141535 [TBL] [Abstract][Full Text] [Related]
19. Umbilical Cord Blood-Derived M1 Macrophage Exosomes Loaded with Cisplatin Target Ovarian Cancer Zhang X; Wang J; Liu N; Wu W; Li H; Lu W; Guo X Mol Pharm; 2023 Nov; 20(11):5440-5453. PubMed ID: 37819754 [TBL] [Abstract][Full Text] [Related]
20. FSTL1 increases cisplatin sensitivity in epithelial ovarian cancer cells by inhibition of NF-κB pathway. Liu YK; Jia YJ; Liu SH; Ma J Cancer Chemother Pharmacol; 2021 Mar; 87(3):405-414. PubMed ID: 33392640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]